摘要
目的观察阿奇霉素治疗婴幼儿急性细菌性肺炎的有效性与安全性。方法采用开放随机对照试验方法,以红霉素作为对照药物,比较研究阿奇霉素治疗婴幼儿急性细菌性肺炎的临床疗效和安全性。结果阿奇霉素组的痊愈率和总有效率分别为75.5%和90.6%,不良反应发生率为9.3%;而红霉素组的痊愈率和总有效率分别为36.0%和68.0%,不良反应发生率为30.4%。两组比较,差异均有统计学意义(均P〈0.05)。结论阿奇霉素治疗婴幼儿急性细菌性肺炎,方便、安全、有效。
Objective To evaluate the clinical efficacy and safety of injection azithromycin in the treatment of the acute bacteria pneumonia of infant. Methods A randomized controlled open trial was carried out. Erythromycin as a controll drug was compared the clinical efficacy and safety with azithromycin as a test drug. Results In azithromycin group,the clinical effective rate was 90. 6% ;the fully recovered rate was 75. 5%. While those of erythromycin group were 68.0% ,36.0% respectively. The incidence of adverse reaction was 9. 3% and 30. 4% respectively in two groups. Conclusion Injection azithromycin of new macrolides type is a kind of effective and safe anti-bacterial drug.
出处
《中国基层医药》
CAS
2008年第10期1617-1618,共2页
Chinese Journal of Primary Medicine and Pharmacy
关键词
肺炎
支原体
阿奇霉素
红霉素
儿童
Pneumonia, mycoplasma
Azithromgcin
Erythromycin
Child